Evidence map›Paper›PMID 26173901›Full record

ArticleScientific reports2015

ZBTB20 is a sequence-specific transcriptional repressor of alpha-fetoprotein gene.

Hai Zhang, Dongmei Cao, Luting Zhou, Ye Zhang, Xiaoqin Guo, Hui Li, Yuxia Chen, Brett T Spear, Jia-Wei Wu, Zhifang Xie and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Isolation and characterisation of AFPStem cell research & therapy · 2025
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Alpha-fetoprotein: A Multifaceted Player in Cancer Biology.Euroasian journal of hepato-gastroenterology
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Hai Zhang1] Department of Pathophysiology, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China [2].
Dongmei Cao1] Department of Pathophysiology, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China [2].
Luting Zhou1] Department of Pathophysiology, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China [2].
Ye ZhangDepartment of Pathophysiology, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China.
Xiaoqin GuoDepartment of Pathophysiology, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China.
Hui LiDepartment of Pathophysiology, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China.
Yuxia ChenDepartment of Pathophysiology, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China.
Brett T SpearDepartment of Microbiology, Immunology &Molecular Genetics, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536, USA.
Jia-Wei WuMOE Key Laboratory for Bioinformatics, School of Life Sciences, Tsinghua University, Beijing 100084, China.
Zhifang XieDepartment of Pathophysiology, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China.
Weiping J ZhangDepartment of Pathophysiology, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China.
Second Military Medical University · CNTsinghua University · CNUniversity of Kentucky · US

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers · 2013 to 2026
$38.3M
RORalpha and Hepatic Zonal RegulationR01DK074816 · NIDDK · UNIVERSITY OF KENTUCKY · PI SPEAR, BRETT T · 2007 to 2021
$3.8M
NCI NIH HHS P30 CA177558NIDDK NIH HHS R01 DK074816
6 · The paper itself

Abstract

Alpha-fetoprotein (AFP) represents a classical model system to study developmental gene regulation in mammalian cells. We previously reported that liver ZBTB20 is developmentally regulated and plays a central role in AFP postnatal repression. Here we show that ZBTB20 is a sequence-specific transcriptional repressor of AFP. By ELISA-based DNA-protein binding assay and conventional gel shift assay, we successfully identified a ZBTB20-binding site at -104/-86 of mouse AFP gene, flanked by two HNF1 sites and two C/EBP sites in the proximal promoter. Importantly, mutation of the core sequence in this site fully abolished its binding to ZBTB20 in vitro, as well as the repression of AFP promoter activity by ZBTB20. The unique ZBTB20 site was highly conserved in rat and human AFP genes, but absent in albumin genes. These help to explain the autonomous regulation of albumin and AFP genes in the liver after birth. Furthermore, we demonstrated that transcriptional repression of AFP gene by ZBTB20 was liver-specific. ZBTB20 was dispensable for AFP silencing in other tissues outside liver. Our data define a cognate ZBTB20 site in AFP promoter which mediates the postnatal repression of AFP gene in the liver.

Indexed as

alpha-FetoproteinsAnimalsBase SequenceBinding SitesDNAElectrophoretic Mobility Shift AssayGenes, ReporterHep G2 CellsHumansLiverMiceMice, KnockoutMutationPromoter Regions, GeneticProtein BindingRatsalpha-FetoproteinsDNATranscription FactorsZbtb20 protein, mouse

Identifiers

PMID26173901
PMCPMC4648434
OpenAlexW2240012855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.